A generic form of the Bristol-Myers Squibb anticoagulant Plavix saw launch by Canadian generic drug maker Apotex, delivering a big blow to BMS. The launch came today, shortly after BMS noted in a ...

The researchers found that the primary outcome was experienced by 17.6% of patients prescribed Plavix and 17.9% prescribed clopidogrel at 1 year (hazard ratio, 1.02; 95% confidence interval, 0.96 to 1 ...

A federal appeals court upheld an injunction putting a halt to Apotex’s sale of a generic version of the blockbuster heart drug Plavix, The Wall Street Journal reported. The US Court of Appeals for ...

> Bristol-Myers Squibb says that it expects Apotex to quickly begin delivering a generic version of its blockbuster anti-blood clotting drug Plavix. Apotex had agreed to delay rolling out a generic ...

A generic version of the standard antiplatelet agent clopidogrel used in Italy may do a worse job of suppressing platelet reactivity than the brand-name form of the drug, according to lab data from an ...

New York, NY - A bid by generic drug maker Apotex to render invalid the patent on Sanofi-Aventis/Bristol-Myers Squibb's Plavix (clopidogrel) has been rejected. On ...

PARIS/LONDON (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday. Plavix, ...

ZURICH, Aug 6 (Reuters) - Novartis AG will sell a generic version of Sanofi-Aventis SA's Plavix blood-thinner at a discount of about 25 percent in Germany, it said on Wednesday. Novartis unit Hexal ...

Bristol-Myers Squibb Co. and Sanofi-Aventis on Thursday won a bid to stop Apotex Inc. from selling its cheaper generic version of the Plavix heart pill, the world’s second-biggest-selling medicine.

Plavix is also given to those who have unstable angina or peripheral artery disease. Using Plavix in combination with aspirin may be more effective in preventing another heart attack, but this will ...

pink opioid pills Clopidogrel noninferior for patients older than 65 years after acute coronary syndrome hospitalization. (HealthDay News) — For patients aged older than 65 years with an acute ...